hrp0086p1-p220 | Diabetes P1 | ESPE2016

Effect of Allopurinol Versus Angiotensin Converting Enzyme Inhibitors in Decreasing Microalbuminuria in Type 1 Diabetic Patients

Elbarbary Nancy , El-Samahy Mona , Abo-El-Asrar Mohamed , Sallam Dina

Background: Diabetic nephropathy is a major microvascular complication of diabetes. It affects 25–35% of diabetic patients diagnosed under the age of 30 years. It is the leading cause of premature death in young diabetic patients.Objective and hypotheses: This study was primary designed to assess the short-term effect (6 months) of allopurinol treatment compared to angiotensin-converting enzyme inhibitor (ACEI) and placebo in type 1 diabetic patient...